Definition
Palladium-based anticancer drugs are a range of compounds containing the platinum group metal (PGM), palladium, in one of its various forms including metallic palladium (Pd(0)) and palladium ions in either the 2+ or 4+ oxidation states. In addition, radioactive 103Pd has also been used in cancer therapeutics. Examples include its use in fluoroscopy, a medical imaging technique which involves the real-time observation of internal organs, and in brachytherapy which uses medical implants of radioactive palladium-103 seeds.
Characteristics
In this section, the advantages and disadvantages of palladium-based drugs over other metal-based drugs will be considered, specifically focusing on the inherent chemical and physical properties of palladium and how these influence drug–DNA interactions.
Palladium
Palladium is a platinum group metal and as such is very similar to platinum...
References
Abu-Surrah AS, Kettunen M (2006) Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin. Curr Med Chem 13:1337–1357
Abu-Surrah AS, Al-Sa’doni HH, Abdalla MY (2008) Palladium-based chemotherapeutic agents: Routes toward complexes with good antitumor activity. Cancer Ther 6:1–10
Aliwaini S, Swarts AJ, Blanckenberg A, Mapolie SF, Prince S (2013) A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy. Biochem Pharm 86:1650–1663
Aliwaini S, Peres J, Kröger WL, Blanckenberg A, de la Mare J, Edkins AL, Mapolie SF, Prince S (2014) The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells. Cancer Lett 357:206–218
Blasko JC, Grimm PD, Sylvster JE, Badiozamani KR, Hoak D, Cavanagh W (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839–850
Caires ACF (2007) Recent Advances Involving Palladium (II) Complexes for the Cancer Therapy. Anticancer Agents Med Chem 7:484–491
Gao E, Sun Y, Liu Q, Duan L (2006) An anticancer metallobenzylmalonate: crystal structure and anticancer activity of a palladium complex of 2,2'-bipyridine and benzylmalonate. J Coord Chem 59:1295–1300
Gao E-J, Wang K-H, Gu X-F, Yu Y, Sun Y-G, Zhang W-Z, Yin H-X, Wu Q, Zhu M-C, Yan X-M (2007) A novel binuclear palladium complex with benzothiazole-2-thiolate: Synthesis, crystal structure and interaction with DNA. J Inorg Biochem 101:1404–1409
Gao E, Liu C, Zhu M, Lin H, Wu Q, Liu L (2009) Current Development of Pd (II) Complexes as Potential Antitumor Agents. Anticancer Agents Med Chem 9:356–368
Kapdi AR, Fairlamb IJS (2014) Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes. Chem Soc Rev 43:4751–4777
Mazor O, Brandis A, Plaks V, Neumark E, Rosenbach-Belkin V, Salomon Y, Scherz A (2005) WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model. J Photochem Photobiol 81:342–351
Ramachandran L, Krishan CV, Nair CKK (2010) Radioprotection by α-Lipoic Acid Palladium Complex Formulation (POLY-MVA) in Mice. Cancer Biother Radiopharm 25:395–399
Trachtenberg J, Bogaards A, Weersink RA, Haider MA, Evans A, McCluskey SA, Scherz A, Gertner MR, Yue C, Appu S, Aprikian A, Savard J, Wilson BC, Elhilali M (2007) Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response. J Urol 178:1974–1979
See Also
(2012) AKT. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 115. doi:10.1007/978-3-642-16483-5_163
(2012) Antioxidant. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 216. doi:10.1007/978-3-642-16483-5_328
(2012) Cancer stem cells. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 626. doi:10.1007/978-3-642-16483-5_815
(2012) Caspase. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 674–675. doi:10.1007/978-3-642-16483-5_873
(2012) Cell cycle. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_994
(2012) Cell death. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_6724
(2012) Cell lines. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 738. doi:10.1007/978-3-642-16483-5_1002
(2012) Clearance. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 880. doi:10.1007/978-3-642-16483-5_1211
(2012) Clinical trial. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 883–884. doi:10.1007/978-3-642-16483-5_1216
(2012) Combination chemotherapy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 952. doi:10.1007/978-3-642-16483-5_6902
(2012) Cytotoxic. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1058. doi:10.1007/978-3-642-16483-5_1499
(2012) DNA. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1129. doi:10.1007/978-3-642-16483-5_1663
(2012) DNA replication. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1141. doi:10.1007/978-3-642-16483-5_1690
(2012) Dose rate. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1155. doi:10.1007/978-3-642-16483-5_1715
(2012) Fluoroscopy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 1426–1427. doi:10.1007/978-3-642-16483-5_2215
(2012) Half-life. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1625. doi:10.1007/978-3-642-16483-5_2554
(2012) Isotope. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1921. doi:10.1007/978-3-642-16483-5_3164
(2012) Lipophilicity. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2058. doi:10.1007/978-3-642-16483-5_3384
(2012) Mitogen-activated protein kinase. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2336. doi:10.1007/978-3-642-16483-5_3770
(2012) Oligonucleotide. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2606. doi:10.1007/978-3-642-16483-5_4207
(2012) Phase I and II clinical trials. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2852. doi:10.1007/978-3-642-16483-5_4504
(2012) Phospholipid bilayer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2869. doi:10.1007/978-3-642-16483-5_4541
(2012) Photosensitizer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2881–2882. doi:10.1007/978-3-642-16483-5_4559
(2012) Prostate cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 3009–3010. doi:10.1007/978-3-642-16483-5_6576
(2012) Radiation therapy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3144. doi:10.1007/978-3-642-16483-5_4907
(2012) Salvage chemotherapy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3334. doi:10.1007/978-3-642-16483-5_6947
(2012) STAT. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3502. doi:10.1007/978-3-642-16483-5_5481
(2012) Therapeutic efficacy. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3667. doi:10.1007/978-3-642-16483-5_5764
(2012) Thrombosis. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3678. doi:10.1007/978-3-642-16483-5_5795
(2012) Toxicity. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3731. doi:10.1007/978-3-642-16483-5_5868
(2012) Transcription. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3752. doi:10.1007/978-3-642-16483-5_5899
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Prince, S., Mapolie, S., Blanckenberg, A. (2015). Palladium-Based Anti-Cancer Therapeutics. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_7085-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_7085-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences